NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ t-cell-mediated immunity and protection against NY-ESO-1+ tumors (Q40564045)
Jump to navigation
Jump to search
scientific article published on April 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ t-cell-mediated immunity and protection against NY-ESO-1+ tumors |
scientific article published on April 2004 |
Statements
1 reference
NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ t-cell-mediated immunity and protection against NY-ESO-1+ tumors (English)
1 reference
Andreas Suhrbier
1 reference
Eugene Maraskovsky
1 reference
Sigrid Sjölander
1 reference
Debbie P Drane
1 reference
Max Schnurr
1 reference
Thuy T T Le
1 reference
Luis Mateo
1 reference
Thomas Luft
1 reference
Tsin-Yee Tai
1 reference
Qiyuan Chen
1 reference
Simon Green
1 reference
Anders Sjölander
1 reference
Martin J Pearse
1 reference
Francois A Lemonnier
1 reference
Weisan Chen
1 reference
Jonathan Cebon
1 reference
1 April 2004
1 reference
1 reference
Identifiers
1 reference